Paxman - Game Changer on the Horizon
2021-06-16 09:00:00
Redeye initiates coverage of Paxman, a Swedish/English medical technology company. They develop, produce, and market their scalp cooling system that reduces hair loss (alopecia) associated with chemotherapy. We see an attractive case with significant upside potential. Strong clinical data and positive drivers for reimbursement in the US are the right ingredients for an exciting growth journey.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/